key: cord-0764179-j39d14vs
authors: Alshammari, Mohammed B; Ramadan, Mohamed; Aly, Ashraf A; El-Sheref, Essmat M.; Bakht, Md Afroz; Ibrahim, Mahmoud A.A.; Shawky, hmed M.
title: Synthesis of potentially new Schiff bases of N-substituted-2-quinolonylacetohydrazides as anti-Covid-19
date: 2020-11-16
journal: J Mol Struct
DOI: 10.1016/j.molstruc.2020.129649
sha: bbb89ca9b11547c238e2430ae6cf68727e69615a
doc_id: 764179
cord_uid: j39d14vs

We report herein a new series of synthesized N-substituted-2-quinolonylacetohydrazides aiming to evaluate their activity towards SARS-CoV-2. The structures of the obtained products were fully confirmed by NMR, mass, IR spectra and elemental analysis as well. Molecular docking calculations showed that most of the tested compounds possessed good binding affinity to the SARS-CoV-2 main protease (M(pro)) comparable to Remdesivir.

| P a g e Highlights:

• Synthesis of new series of quinolone N-substituted-2-quinolonylacetohydrazides • NMR spectral investigation of the newly prepared compounds.

• Molecular docking of the binding affinity to COVID-19 was done using Remdesivir as a reference • Compound N'-(3-methoxybenzylidene)-2-quinolinacetohydrazide derivative showed high electron affinity towards COVID-19 and compared with Remdesivir

Recently World Health Organization (WHO) declared the resulting disease named COVID-19 as a pandemic [1, 2] . It is safe to say that a sufficient understanding of SARSCoV-2, and the full clinical picture of the resulting COVID-19 disease will take some time [3] [4] [5] [6] [7] [8] .

Remdesivir ( Figure 1 ) an adenosine analogue, has been recently recognized as a promising antiviral drug against a wide array of RNA viruses (including SARS/MERS-CoV) [9, 10] infection in cultured cells, mice and nonhuman primate (NHP) models. It is currently under clinical development for the treatment of the Ebola virus infection [11] . Remdesivir binds to ribonucleic acid (RNA)-dependent RNA polymerase and acts as an RNA-chain terminator. It displays potent in vitro activity against SARS-CoV-2 with an EC50 at 48 hours of 0.77 µM in Vero E6 cells.

Remdesivir is highly selective for viral polymerases and is therefore expected to have a low propensity to cause human toxicity [12] .

During last few decades, 4-hydroxy-2-quinolones as privileged structures in drug discovery are beyond doubt, one of the major areas in medicinal chemistry [13] [14] [15] . The 4-hydroxy-2quinolinones scaffold is widely found in alkaloids [16] and they are important as a characteristic building block for a series of significant biologically active compounds. Many efforts have been done on antiviral properties of quinolines and quinolones and their structural analogues against the human immunodeficiency virus (HIV), but their antiviral activity was also demonstrated against the human cytomegalovirus (HCMV), SARS corona virus, Zika virus, Chikungunya virus, hepatitis C virus (HCV), and Ebola virus [17] [18] [19] [20] [21] [22] . The mechanism of action of antiviral quinolone remains unclear. Specific studies aimed at understanding the nature of drug's targets at the molecular level indicated that quinolones inhibit viral transcription [23] .

Elvitegravir, (Figure 2 ) is the first quinolone-based anti-HIV drug, exhibiting potent inhibitory activity against integrase-catalyzed DNA strand transfer [24, 25] . Another series of quinolone-3carboxylic acids have been synthesized by introducing different hydrophobic groups at the N(1), C(2), C(7), and C(8) positions [26] . Most of the compounds of this group showed anti-HIV activity without cytotoxicity at a concentration of 100 μM. biologically active compounds. As an example, 2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3yl)succinic acid derivative I, was obtained by a one-pot reaction of one equivalent of aromatic amines with two equivalents of diethyl malonate in diphenyl ether and catalyzed with triethylamine [27] . A reaction of four equivalents of 4-hydroxyquinolin-2(1H)-one with one equivalent of acenaphthoquinone gave acenaphthylene-1,1,2,2-tetrayl-tetrakis(4-hydroxyquinolin-2(1H)-one) (II, [28] . We also reported that quinoline-2,4-dione reacted with 2-(2-oxo-1,2-dihydroindol-3ylidene)malononitrile in pyridine to give spiro(indoline-3,4'-pyrano[3,2-c]quinoline)-3'-carbonitrile (III, [29] , whereas 2-quinolone reacted with diethyl acetylenedicarboxylate to give pyrano [3,2- c]quinoline-4-carboxylate (IV, [30] . Also a class of 1,2,3-triazoles derived by 2-quinolone (V, [31] ) was synthesized, via Cu-catalyzed [3+2]cycloadditions (Meldal-Sharpless 'click'-reactions) [31] .

We also synthesized naphthofuro [3,2- [34] . Most indicative is our recent synthesis of 6-substiuted-4-(2-(4-substituted-benzylidene)hydrazinyl)quinolin-2(1H)-one derivative XII [35] which was evaluated for their in vitro cytotoxic activity against 60 cancer cell lines according to NCI protocol [35] .

On the other hand, Schiff bases have large importance in medicinal and pharmaceutical fields due to a broad spectrum of biological activities like analgesic [ -36,38,40] , anti inflammatory [ -39], anti -36 [42, 43] , and so forth. cancer -tubercular [41] , anti So, from the highly biological and pharmaceutical activities of 4-hydroxy-2-quinolinones and Schiff bases, we focused in our paper to merging the activity of these compounds and compare them with Remdesivir (as one of the prospective drugs)

against COVID-19. This was fully supported by its 1 H NMR spectrum, which displayed a characteristic singlet at H = 11.80, 11.34 ppm, integrating for two D2O exchangeable protons which were assigned as NH-4e

and NH-1, respectively. Also, a singlet at H = 5.33 ppm (2H) corresponding to -OCH2-(H-4c) was further confirmed from 13 C NMR ( Figure 5 ) with a characteristic singlet at C = 65.15 ppm (Table   1 ). The protons of the phenyl group exhibit a 1,4-disubstituted system and was observed as a doublet- as C-4d, quinolone-C-2, C-4, C=N (C-4g), and methyl group (C-7a), respectively ( Table 2 ). In 15 N-NMR, the signal at N = 317.2 ppm, indicated as N-4f gave HMBC correlation with proton at H = 8.01 ppm which was assigned as H-4g and didn't have any HSQC correlation, and this proton give HSQC correlation with carbon at 142.93 ppm, which was assigned as C-4g that indicates the absence of hydrazine-NH2 and condensation takes place on it, with other signals at N = 177.9 and 144.4 ppm, which were assigned as N-4e and N-1, respectively, and these nitrogen gave an HSQC correlation which indicates that these nitrogen atoms are carrying protons ( Table 2 ). The former correlation indicates the E-form of the azomethine structure. 

To reveal the binding modes and affinities of the synthesized compounds 4a-k with SARS-CoV-2 main protease (M pro ) and RNA-dependent RNA polymerase (RdRp), molecular docking calculations were performed using Autodock4.2.6 software. The predicted docking scores and binding features of compounds 4a-k with M pro and RdRp receptors are listed in Table 3 . According to the calculated docking scores (Table 3) 

In conclusion, a new series of N-substituted-2-quinolonylacetohydrazides was here synthesized in order to evaluate their activity towards SARS-CoV-2 M pro and RdRp. The NMR spectra ( 1 H, 13 

The authors thank the Deanship of Scientific Research at Prince Sattam Bin Abdulaziz University under the research project No10302/1/2019.

Melting points were determined on Stuart electrothermal melting point apparatus and were 

A mixture of 3a,b (1 mmol), aldehydes (1 mmol) and a few drops of acetic acid in 20 mL of absolute ethanol which was stirred and refluxed for 6-8 h (the reaction was followed by TLC analysis). After the reaction's completion, the solid was filtered off and washed with a hot ethanol to give pure compounds 4a-m.

This compound was obtained as a colorless compound, yield 0. 

The crystal structures of SARS-CoV-2 main protease (M pro ; PDB code: 6LU7 [46] ) and RNAdependent RNA polymerase (RdRp; PDB code: 6M71 [47] ) were taken as templates for all molecular docking. Receptors were cleaned of water molecules, ions and the ligands. The protonation state of M pro and RdRp was investigated using an H ++ server, and all missing hydrogen atoms were added [48] . All molecular docking calculations were carried out using Autodock4.2 software [49] . All docking parameters were kept to default values, except the number of genetic

Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments

Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV

The spike protein of SARS-CoV-a target for vaccine and therapeutic development

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020

Global patterns in coronavirus diversity

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design

pharmacokinetics and concerns about clinical trials for 2019-nCoV infection

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Controlled Trial of Ebola Virus Disease Therapeutics

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Components of Haplophyllum bucharicum

Reactions of 2-methyl-3,1-benzoxazin-4-one with active methylene compounds: a new route to 3-substituted 4-hydroxyquinolin-2(1H)-ones

4-Hydroxy-2-quinolones 121. Synthesis and biological properties of 1-hydroxy-3-oxo-5,6-dihydro-3H-pyrrolo[3,2,1-ij]quinoline-2 carboxylic acid alkyl amides

Quinoline Alkaloids from Euodia roxburghiana

A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication

The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early protein

Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a minireview

bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine

Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases

Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models

Antiviral Properties of Quinolone-based Drugs

Effects of chloroquine on viral infections: An old drug against today's diseases

Novel HIV-1 integrase inhibitors derived from quinolone antibiotics

Novel quinolone-3-carboxylic acid derivatives as anti-HIV-1 agents: design, synthesis, and biological activities

One-pot synthesis of 2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)succinates and arylmethylene-bis-3,3′-quinoline-2-ones

Reactions of 4-hydroxyquinolin-2(1H)-ones with acenaphthoquinone: synthesis of new 1,2-dihydroacenaphthylene-spiro-tetrakis(4-hydroxy-quinolin-2(1H)-ones)

Synthesis of spiro

Synthesis of pyrano[3,2-c]quinoline-4-carboxylates and 2-(4-oxo-1,4-dihydroquinolin-3-yl)fumarates

New 4-(1,2,3-triazolo)quinolin-2(1H)-ones via Cu-catalyzed [3+2] cycloaddition

synthesis and biological evaluation of fused naphthofuro[3,2-c]quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma

Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies

Synthesis of new fused heterocyclic 2-quinolones and 3-alkanonyl-4-hydroxy-2-quinolones

Arylidenes of Quinolin-2-one scaffold as Erlotinib analogues with activities against leukemia through inhibition of EGFR TK/ STAT-3 pathways

Synthesis, anti-inflammatory, analgesic and kinase (CDK-1,CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff's bases

Synthesis of Schiff bases of 2-amino-5-aryl-1,3,4-thiadiazole And its Analgesic, AntiInflammatory, Anti-Bacterial and Antitubercular Activity

Synthesis and biological screening of certain new triazole schiff bases and their derivatives bearing substituted benzothiazole moiety

Synthesis, characterization, and analgesic activity of novel Schiff base of isatin derivatives

Synthesis characterization and anti-inflammatory evaluation of new fluorobenzothiazole schiff's bases. Inter

Synthesis, antitubercular activity and pharmacokinetic studies of some Schiff bases derived from 1-alkylisatin and isonicotinic acid hydrazide (INH)

QM study and conformational analysis of an isatin Schiff base as a potential cytotoxic agent

In vivo anticancer activity of vanillin semicarbazone

Synthesis and antimicrobial activity of some new 4-triazolylmethoxy-2H-chromen-2-one derivatives

Synthesis of Novel Quinolone and Coumarin Based 1,3,4-Thiadiazolyl and 1,3,4-Oxadiazolyl -N-Mannich Bases as Potential Antimicrobials

Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Onufriev A. a server for estimating pKas and adding missing hydrogens to macromolecules

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

Iterative partial equalization of orbital electronegativity -A rapid access to atomic charges

algorithm (GA) runs and the maximum number of energy evaluations (eval) which were set to 250 and 25,000,000, respectively. The docking grid was set to 60Å x 60Å x 60Å with a grid spacing value of 0.375 Å, and the grid centre was placed at the centre of the active site. The geometrical structures of all synthesized compounds were minimized with a MMFF94s force field using SZYBKI software [50] and the partial atomic charges were assigned using the Gasteiger method 

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.